
Oncology NEWS International
- Oncology NEWS International Vol 17 No 4
- Volume 17
- Issue 4
Artists take note: Oncology on Canvas accepting entries
The 2008 Oncology on Canvas: Expressions of a Cancer Journey art competition and exhibition, sponsored by Eli Lilly and Company in partnership with the National Coalition for Cancer Survivorship, is accepting entries to be received no later than June 30, 2008.
The 2008 Oncology on Canvas: Expressions of a Cancer Journey art competition and exhibition, sponsored by Eli Lilly and Company in partnership with the National Coalition for Cancer Survivorship, is accepting entries to be received no later than June 30, 2008.
The biennial competition invites people diagnosed with any type of cancer, their families, friends, caregivers, and healthcare providers to express, through art and narrative, the life-affirming changes that give their cancer journey meaning.
Entries can be from any of six different art media: oil, watercolor, acrylic, photography, pastel, and mixed media (any other type of one-dimensional art). Submitted artwork must be at least 12″ × 12″ and no larger than 17″ × 26″.
Artists can enter via three categories: person diagnosed with cancer; healthcare professional, eg, doctor, nurse, pharmacist, lab technician; and family member, friend, or caregiver.
An independent panel of judges will select three top prize winners who will be awarded prize money to be donated directly to a cancer charity of their choice: 1st prize $10,000, 2nd prize $5,000, and 3rd prize $2,500. Additional winners will be selected from each medium and participant category with awards of $1,000.
The 2006 1st prize US winner, for example, donated her winnings to the University of North Carolina Lineberger Comprehensive Cancer Center, while the 3rd prize winnings went to the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins.
For more information or to obtain an entry form and content criteria, please call 1-800-734-4131, or log on to
Articles in this issue
over 17 years ago
Proton therapy training offeredover 17 years ago
Editor of Blood reviews a very bloody movieover 17 years ago
PET affects treatment in over one-third of cancer casesover 17 years ago
Expanded use of Axxent approvedover 17 years ago
Gardasil supplemental application gets priority review designationover 17 years ago
Optical tomo/US monitors adjuvant chemo responseover 17 years ago
GIST patients resistant to imatinib/sunitinib respond to sorafenibover 17 years ago
Sunitinib plus a taxane active in advanced breast cancerover 17 years ago
Stanford V yields excellent outcomes in bulky, advanced HLover 17 years ago
Monica Morrow joins Memorial Sloan-Kettering Cancer CenterNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































